Endothelins: vasoactive modulators of renal function in health and disease

被引:42
|
作者
Naicker, S
Bhoola, KD [1 ]
机构
[1] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Med, ZA-4001 Durban, South Africa
[2] Technikon Natal, Fac Hlth, Ctr REs Dev, ZA-4001 Durban, South Africa
基金
新加坡国家研究基金会;
关键词
endothelin-1; endothelin genes; endothelin receptors; acute transplant rejection; glomerular disease;
D O I
10.1016/S0163-7258(01)00131-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Vasoactive autocoids with directly opposing actions on the renal vasculature, glomerular function, and in salt and water homeostasis have been demonstrated in the kidney. In the renal cortex, endothelin (ET)-1 and angiotensin-II cause vasoconstriction, decreasing renal blood flow, and glomerular filtration rate, whereas bradykinin and atrial natriuretic peptide cause vasodilation and increase glomerular capillary permeability. ET-I causes vasoconstriction of the afferent and efferent arteries and outer medullary descending vasa recta, thereby decreasing vasa recta and papillary blood flow, while bradykinin has the opposite effect. ET-I stimulates cell proliferation, increasing the expression of several genes, including collagenase, prostaglandin endoperoxidase synthase, and platelet-derived growth factor. ET-I promotes natriuresis via the ET-B receptor, causing down-regulation of the epithelial Na (+) channel in the renal tubule. Thus, ETs affect three major aspects of renal physiology: vascular and mesangial tone, Na+ and water excretion, and cell proliferation and matrix formation. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:61 / 88
页数:28
相关论文
共 50 条
  • [1] VASOACTIVE HORMONES - MODULATORS OF RENAL-FUNCTION
    KIRCHHEIM, HR
    EHMKE, H
    CLINICAL INVESTIGATOR, 1994, 72 (09): : 685 - 687
  • [2] Endothelins and nitric oxide: Vasoactive modulators of carotid body chemoreception
    Rey, S
    Iturriaga, R
    CURRENT NEUROVASCULAR RESEARCH, 2004, 1 (05) : 465 - 473
  • [3] Endothelins and nitric oxide: Vasoactive modulators of carotid body chemoreception
    Hunt, BJ
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) : 787 - 788
  • [4] Endothelins in health and disease
    Shah, Rahman
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2007, 18 (04) : 272 - 282
  • [5] VASOACTIVE MEDIATORS RELEASED BY ENDOTHELINS
    HYSLOP, S
    DENUCCI, G
    PHARMACOLOGICAL RESEARCH, 1992, 26 (03) : 223 - 242
  • [6] Endothelins in health and disease: An overview
    Goldie, RG
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (02) : 145 - 148
  • [7] ENDOTHELINS IN THE CONTROL OF CARDIOVASCULAR AND RENAL-FUNCTION
    REMUZZI, G
    BENIGNI, A
    LANCET, 1993, 342 (8871): : 589 - 593
  • [8] Endothelins – vasoactive peptides and growth factors
    Martin Stjernquist
    Cell and Tissue Research, 1998, 292 : 1 - 9
  • [9] ENDOTHELINS - A NEW FAMILY OF VASOACTIVE PEPTIDES
    LEVESQUE, H
    MOORE, N
    THUILLEZ, C
    COURTOIS, H
    THERAPIE, 1992, 47 (01): : 53 - 56
  • [10] Endothelins - vasoactive peptides and growth factors
    Stjernquist, M
    CELL AND TISSUE RESEARCH, 1998, 292 (01) : 1 - 9